Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...
An FDA-approved digital therapeutic (DTx) that can be used to help people living with major depressive disorder (MDD) has been launched in the US and is available in mobile app stores. Otsuka Pharma ...
Clickr' and 'cardsforfun' butted heads in the $1,000-$2,000 no-limit hold'em games on CoinPoker, with Clickr booking a decent ...
For all investors looking to unearth stocks that are poised to move. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and ...
For all investors looking to unearth stocks that are poised to move. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback